Stocktwits on MSN

Philip Morris Seeks FDA Approval To Keep IQOS Modified Risk Designation For Later Versions Of Device

Philip Morris International Inc. (PM) said on Wednesday that its experts met with the Tobacco Products Scientific Advisory ...

Philip Morris International seeks FDA approval to keep marketing IQOS as reduced risk product

The FDA granted the MRTP designation to the IQOS system in 2020 for an initial four-year period. The evidence presented to ...
TipRanks on MSN

Philip Morris urges TPSAC to recommend continued marketing of IQOS as MRTP

International presented evidence to the Tobacco Products Scientific Advisory Committee. The committee, comprised ...
Agence France-Presse

Philip Morris International Urges U.S. Food and Drug Administration Advisory Committee to Recommend Continued Marketing of IQOS as Modified Risk Product

Experts from Philip Morris International Inc. (NYSE: PM) presented evidence to the Tobacco Products Scientific Advisory Committee (TPSAC). The committee, comprised of independent scientific ...

PMI Urges FDA To Renew IQOS MRTP Status, Citing Strong Evidence Of Reduced Harm And Switching

Philip Morris International Inc. (PM) announced that it recently presented evidence to the Tobacco Products Scientific Advisory Committee (TPSAC), a panel of independent ...
Morningstar

PMI Moves Closer to U.S. iQOS Distribution As It Ditches Altria and Raises Offer for Swedish Match

Altria, the leading U.S. cigarette manufacturer, and Philip Morris International have reached an agreement under which Altria will forgo the exclusive rights to commercialize iQOS, PMI's heated ...